SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $51,356,000 | -22.8% | 366,068 | +0.7% | 2.62% | -16.0% |
| Q2 2019 | $66,541,000 | +19.4% | 363,432 | +3.7% | 3.12% | +11.4% |
| Q1 2019 | $55,726,000 | +311.4% | 350,368 | +147.7% | 2.80% | +251.4% |
| Q4 2018 | $13,547,000 | -31.3% | 141,426 | +1.3% | 0.80% | -8.5% |
| Q3 2018 | $19,725,000 | +4.7% | 139,646 | +16.0% | 0.87% | -9.9% |
| Q2 2018 | $18,847,000 | +26.4% | 120,408 | +30.1% | 0.97% | +15.5% |
| Q1 2018 | $14,912,000 | – | 92,583 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |